Just listened to the Dr Been interview.
*** warning -
Just listened to the Dr Been interview.
*** warning - this may sound like a soft bash , but its just someone frustrated. If you look at my past posts , especially when people were calling for early unblinding - i was not in favor for the exact reason we see now - trial size matters.
This post may even sound as random as some of that interview. so skip now.
I am so confused by this interview. NP really shouldn't be allowed to speak in front of people. He rust rambles.
Here is what I need help understanding :
- still no understanding why FDA (apparently) said no M/M - maybe they said - for M/M we need 2000 sample and NP went "oh, that sounds like a lot of money"... who knows
- for someone with a phd in mechanical engineering he should understand stats. Is there a reason he can't understand that scientists need data (usually a lot of it) for these types of tests.
- why are they only focusing on critical - why not go for S and C as 2 different populations. What we got was - why do 400 more (money?), instead of 2 at once, we will gamble on C and hope. My old boss used to say "hope is not a strategy".
- NP is always blaming others - ie the 200K vials to Philippines. Stop sounding like a CEO that has no clue how things work.
- the scary part is he promises constant video starting next week.
- on a medical show only talks stock price, his history with the company. Never about the science etc.
- the whole talk about raising money etc - thats just not needed here. why even say all that?
- no hearing about BLA for HIV etc.
- why no talk about S ?
- please publish the data from the trial about how it effected the cytokine storm?
- was the 6 day over everyone or just the 62 C's ?
I really wish we had a better team. There is a reason this company is an easy target for shorts.
PS. I have other questions - demoxy - at first glance wouldn't that interfere with LL ? Would that have effected the trial ?
6
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Breaking Ground in Data Center Power Every so often, the tech industry gets a jolt of innovation that turns heads—not just for what it can do today, but for what it promises tomorrow. This time, it's United Microelectronics Corporation (UMC) and AP Memory shaking things up with their collaboration aimed at redefining power delivery for AI and high-performance computing...
Continue Reading
A New Phase for Chinese Pharmaceuticals There's a shift in the pharma world, with Fosun International leading the charge. Chinese innovative drugs are stepping onto the global stage, thanks to efforts like those of Chen Qiyu, Co-CEO of Fosun. At the Sustainability Global Leaders Conference 2026, he spoke about transforming Chinese market players into worldwide...
Continue Reading
A New Chapter for FirstService Residential Picture this: a property management powerhouse dialing up their Jacksonville operations with a shiny new office move. FirstService Residential, North America's big shot in property management, has swapped location to a swish setup on Southpoint Drive South in Jacksonville, Florida, aiming to supercharge collaboration and give a...
Continue Reading
AI Infrastructure Takes Center Stage Grab your coffee because Verda and Compal are shaking up the AI scene with their latest announcement from GTC Berlin 2026. The duo's expanding their collaboration, and if you're watching the markets, this isn't something you can ignore. With Verda's AI cloud muscle and Compal's beefed-up global manufacturing, we're talking about a...
Continue Reading
Trouble Brewing for Compass Investors Amidst Legal Storm In the tangled web of mergers and acquisitions, Compass, Inc. (NYSE: COMP) finds itself in a legal quagmire that has investors on edge. The stark reality of a securities fraud class action lawsuit has emerged, centered around Compass’s January 2026 merger with Anywhere Real Estate Inc. The Heart of the Allegations...
Continue Reading
Fielding Opportunities in a Revved-Up Market You're knee-deep in grease and exhaust, keeping your motorsport enterprise alive against the big dogs without losing grip on the little guy's budget. What if I told you there's a service out there talking your language – combining marketing prowess with AI smarts for as low as $350 a month? That's ALIVE and Track Rabbit...
Continue Reading
Innovating Financial Analysis with AI They said AI would change everything, but who knew it'd make such a wave in turning research ideas into actionable datasets? RavenPack's latest maneuver is rewriting the playbook. By leveraging a fine-tuned NVIDIA Nemotron model, they've managed to label a mind-boggling 845,220 financial-text excerpts in under an hour. It's not just...
Continue Reading
A Brew of Legal Consequences for Heineken If this isn't a financial wake-up call for the brewing giant, I don't know what is. In the latest twist of corporate accountability, the Amsterdam District Court has ordered Heineken and its Greek subsidiary, Athenian Brewery, to cough up a whopping €111 million. And we're not just talking pocket change—this ruling speaks...
Continue Reading
Eightpoint Technologies Steps Up for a Crucial Cause Kicking in when it counts, Eightpoint Technologies has done something that might not turn stock market heads but speaks volumes about corporate responsibility. They're ponying up for a year's worth of groceries for the Cayman Islands Crisis Centre (CICC) starting November 1, 2026. We're talking real relief for women and...
Continue Reading
Bose Broadens Horizons with Skullcandy Acquisition Well, here's a twist that rattles my morning coffee mug: Bose goes and buys Skullcandy. That’s right, the audio bigwig known for polished sound just snapped up the edgier, younger sibling in earbuds. Bose ain't just playing with sound anymore; they're grabbing lifestyle by the horns, hoping Skullcandy's flair will shake...
Continue Reading
Top 5 Most Recently Viewed Articles
Green Thumb's Newest RISE Dispensary Opening in Nevada Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF) is set to enhance its footprint in the cannabis sector with the grand opening of the RISE Dispensary Henderson on Boulder. Located in a prime area, this new venue will serve both medical patients and adult consumers, providing a variety of high-quality cannabis...
Continue Reading
Introducing Manojo Mezcal Celebrated chef Enrique Olvera, known for his excellence in the culinary world, has teamed up with a group of talented individuals to launch Manojo Mezcal. This new venture pays homage to the vibrant culture of Oaxaca through a distinct Espadín mezcal. The Essence of Oaxaca Manojo Mezcal encapsulates the rich tapestry of Oaxaca's traditions,...
Continue Reading
Validity Strengthens Its Position in Marketing Solutions Validity, Inc., recognized as a leader in providing marketing success and customer data intelligence solutions, has successfully completed the acquisition of Litmus. This strategic move is aimed at enhancing Validity's offerings in email optimization and testing solutions, ultimately reinforcing its mission to...
Continue Reading
Biodesix Reports Impressive Preliminary Financial Results Biodesix, Inc. (Nasdaq: BDSX) has made a significant announcement regarding its preliminary financial results for the fourth quarter and the full year ending in December 2024. These figures, though provisional and unverified, usher in a positive outlook for the diagnostic solutions company based in Louisville,...
Continue Reading
Electrolux Group's Third Quarter Highlights Electrolux Group has recently shared impressive findings in their latest report for the third quarter of 2024. In this period, net sales have reached a remarkable SEK 33,286 million, showcasing a slight decrease from last year, but representing a robust organic sales growth of 6.2%. This increase is primarily attributed to a...
Continue Reading